Moderna, JFrog, TransMedics, Ubiquiti And Other Big Stocks Moving Higher On Friday
U.S. stocks rose, Nasdaq gained ~400 points. Moderna jumped 9.1% on strong Q3 results and higher FY26 guidance; other stocks rallied on results and deals.
Stocks · News reference
Shares of uranium and nuclear-related companies are trading lower amid multiple catalysts including reports suggesting Oracle has issued a "force majeure" notice regarding potential timeline slippage of Project Jupiter in New Mexico, which may imply slower data center development. Also, Google's launch of Project Suncatcher to deploy AI compute capacity in space may dampen expectations for nuclear power needs.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
This Palatin Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday
Analysts initiated coverage: Neutral on KEEL ($2), Buy on PTN ($12), FRVO ($17) and YARW ($60).
Barclays Maintains Equal-Weight on Centrus Energy, Lowers Price Target to $149
Why Is Oklo Stock Gaining Friday?
Oklo stock rises after Q3 revenue beats estimates, Aurora reactor construction advances and a new manufacturing deal supports expansion.
Canaccord Genuity Upgrades Centrus Energy to Buy
Canaccord Genuity has upgraded Centrus Energy to Buy with a price target of CA$37.50.
Barclays Adjusts Centrus Energy Price Target
Barclays maintained its Hold rating on Centrus Energy while lowering the price target to $149 from $150.